MBOAT1

Membrane-bound glycerophospholipid O-acyltransferase 1 · Q6ZNC8 · MBOAT1 on Sugi Atlas →

0 patent compounds predicted against MBOAT1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MBOAT1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Omega-3 Fatty Acids on the Human Gene Expression PHASE4COMPLETED
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Lovaza's Effect on the Activation of Platelets PHASE2COMPLETED
Ambroxol as a Treatment for Parkinson's Disease Dementia PHASE2UNKNOWN
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients PHASE2COMPLETED
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease PHASE2COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
Epidemiology of Atherosclerosis nanCOMPLETED
RCDP Natural History Study nanUNKNOWN
Human Requirements for the Nutrient Choline nanCOMPLETED
Choline to Improve Malnutrition and Enhance Cognition nanRECRUITING
Study of Chediak-Higashi Syndrome nanRECRUITING
Structural Network on Prostate Cancer in the French Greater West Region nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING
A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism nanCOMPLETED
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies nanCOMPLETED
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline nanCOMPLETED
Impact Of Choline in Patients With NAFLD nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MBOAT1 binder may also engage these)

ProteinNameSimilarity
Q8BH98 1.000 Q8BH98 →
Q5ZKL6 0.996 Q5ZKL6 →
Q3T1J2 0.995 Q3T1J2 →
Q6ZWT7 0.992 Q6ZWT7 →
Q8R3I2 0.992 Q8R3I2 →
A8WXS4 0.991 A8WXS4 →
O01925 0.988 O01925 →
Q9VVX5 0.988 Q9VVX5 →
Q9VMD5 0.986 Q9VMD5 →
Q91V01 0.986 Q91V01 →
Q19468 0.985 Q19468 →
Q3SZL3 0.985 Q3SZL3 →
Q5FVN0 0.983 Q5FVN0 →
LPCAT3 Lysophospholipid acyltransferase 5 0.982 landscape →
O42916 0.981 O42916 →
B1Q006 0.981 B1Q006 →
A0A161IUT7 0.980 A0A161IUT7 →
Q9SLD2 0.979 Q9SLD2 →
A0A0P0WY03 0.979 A0A0P0WY03 →
A8WZ09 0.979 A8WZ09 →
Q6NN55 0.978 Q6NN55 →
Q9VZU2 0.978 Q9VZU2 →
K7LC65 0.977 K7LC65 →
I1MSF2 0.977 I1MSF2 →
Q7Q3N5 0.976 Q7Q3N5 →
Q08548 0.976 Q08548 →
Q09758 0.976 Q09758 →
Q22329 0.976 Q22329 →
Q08929 0.975 Q08929 →
Q7Z7B1 0.974 Q7Z7B1 →